Using Cannabis With Ecstasy Did Not Protect Against Ecstasy-Related Cognitive Impairment
Contrary to the hypothesis that cannabis might be neuroprotective against ecstasy damage, people who used both cannabis and ecstasy together showed the same cognitive impairments as those who used ecstasy alone.
Quick Facts
What This Study Found
Researchers reanalyzed data from multiple studies to test whether using cannabis alongside ecstasy (MDMA) might protect against ecstasy-related cognitive damage, based on evidence that cannabinoids can be neuroprotective under certain conditions.
They compared three groups: people who typically use cannabis and ecstasy at the same time, people who use ecstasy without concurrent cannabis, and non-ecstasy users. Testing covered processing speed, random letter generation, verbal and visuospatial working memory, reasoning, and associative learning.
The two ecstasy-using groups did not differ from each other on any measure. Both ecstasy groups performed significantly worse than non-ecstasy users on associative learning, verbal and visuospatial working memory, and reasoning. Cannabis co-use provided no measurable cognitive protection.
Key Numbers
Three groups compared across 6+ cognitive domains. No significant differences between the two ecstasy groups on any measure. Both ecstasy groups significantly worse than controls on associative learning, verbal working memory, visuospatial working memory, and reasoning.
How They Did This
Reanalysis of data from previous studies comparing three groups: concurrent cannabis/ecstasy users, ecstasy-only users, and non-ecstasy controls. Assessed processing speed, random letter generation, verbal and visuospatial working memory span, reasoning, and associative learning.
Why This Research Matters
The idea that cannabis might protect against ecstasy neurotoxicity had theoretical support from cannabinoid neuroprotection research. This study provides a practical reality check: in actual human use patterns, combining cannabis with ecstasy did not result in better cognitive outcomes.
The Bigger Picture
While laboratory research suggests cannabinoids can be neuroprotective in certain experimental conditions, this finding illustrates that such effects may not translate to real-world polysubstance use scenarios. The doses, timing, and biological contexts of recreational use differ substantially from controlled laboratory conditions.
What This Study Doesn't Tell Us
Cross-sectional design cannot establish whether pre-existing differences between groups explain the results. Self-reported drug use patterns may be inaccurate. The reanalysis combined data from studies with potentially different methodologies. Users may differ in unmeasured ways.
Questions This Raises
- ?Could specific cannabinoid doses or timing provide neuroprotection that recreational co-use does not?
- ?Are the cognitive deficits in ecstasy users reversible with sustained abstinence?
Trust & Context
- Key Stat:
- No cognitive difference between ecstasy-only users and those who combined ecstasy with cannabis
- Evidence Grade:
- Reanalysis of cross-sectional data. Provides useful practical evidence but limited by the inherent weaknesses of cross-sectional design and retrospective group comparisons.
- Study Age:
- Published in 2006. Research on polysubstance interactions and cognitive effects has continued to develop.
- Original Title:
- The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?
- Published In:
- Human psychopharmacology, 21(6), 355-66 (2006)
- Database ID:
- RTHC-00225
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Does cannabis protect against ecstasy brain damage?
Not based on this study. People who used cannabis and ecstasy together showed the same cognitive impairments as those who used ecstasy alone, including deficits in memory, reasoning, and learning.
What cognitive effects does ecstasy have?
Both ecstasy-using groups showed significantly worse performance than non-users on associative learning, verbal and visuospatial working memory, and reasoning. Processing speed was not significantly different.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- thc-and-antibiotics-safe-cannabis-while-on
- thc-and-caffeine-most-common-drug-combo
- thc-and-diabetes-medication-blood-sugar
Cite This Study
https://rethinkthc.com/research/RTHC-00225APA
Fisk, John E; Montgomery, Catharine; Wareing, Michelle; Murphy, Philip N. (2006). The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?. Human psychopharmacology, 21(6), 355-66.
MLA
Fisk, John E, et al. "The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?." Human psychopharmacology, 2006.
RethinkTHC
RethinkTHC Research Database. "The effects of concurrent cannabis use among ecstasy users: ..." RTHC-00225. Retrieved from https://rethinkthc.com/research/fisk-2006-the-effects-of-concurrent
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.